103296-32-8 (头孢吡肟杂质E,NMP-ACA (Cefepime Impurity))

1-[[(6R,7R)-7-氨基-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]-1-甲基吡咯烷内盐;头孢吡肟杂质E;1-[[(6R,7R)-7-氨基-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]-1-甲基吡咯烷鎓内盐;头孢吡肟EP杂质E;

NMP-ACA (Cefepime Impurity);(6R,7R)-7-amino-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;NMP-ACA;UNII-OXO94WH649;(6R-trans-NMP-ACA);7-AMino-3-(1-Methylpyrrolidino)Methyl-3-cepheM-4-carboxylate Inner Salt;1-[[(6R,7R)-7-AMino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]Methyl]-1-MethylpyrrolidiniuM Inner Salt;DTXSID60145769;Cefepime impurity E [EP];103296-32-8;Q27285906;J-000924;DA-49045;Cefepime amine derivative;Pyrrolidinium, 1-((7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, inner salt, (6R-trans)-;SCHEMBL8419897;7-Amino-3-((1-methylpyrrolidinio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, (6R,7R)-;DISCONTINUED. Please see A603160.;CS-0112176;OXO94WH649;Cefepime specified impurity E [EP];DE((2-aminothiazol-4-yl)-2-methoxyimino-acetyl)cefepime;(6R,7R)-7-Amino-3-((1-methylpyrrolidinio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate;Pyrrolidinium, 1-(((6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, inner salt;Cefepime dihydrochloride monohydrate impurity E [EP];HY-135371;AKOS040751066;

IIVPIDBZUUAWTF-BXKDBHETSA-N

1S/C13H19N3O3S/c1-16(4-2-3-5-16)6-8-7-20-12-9(14)11(17)15(12)10(8)13(18)19/h9,12H,2-7,14H2,1H3/t9-,12-/m1/s1

S1CC(=C(C(=O)[O-])N2C([C@H]([C@@H]12)N)=O)C[N+]1(C)CCCC1